Stock CRMD CORMEDIX INC.
Add to a list
To use this feature you must be a member
Log inSign up

News CorMedix Inc.

Equities

CRMD

US21900C3088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
5.31 USD +2.31% Intraday chart for CorMedix Inc. +0.57% +41.22%
Apr. 15 CorMedix's DefenCath Now Commercially Available For US Inpatient Use MT
Apr. 15 CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CORMEDIX INC. ANNOUNCES CMS GRANTS TDAPA TO DEFENCATH
AQ
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
AQ
CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL AVAILABILITY OF DEFENCATH
AQ
CorMedix's DefenCath Now Commercially Available For US Inpatient Use
MT
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
AQ
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)
CI
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
AQ
Sector Update: Health Care Stocks Decline Late Afternoon
MT
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization
MT
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
AQ
CorMedix Inc. Announces Commercial Agreement with ARC Dialysis, LLC
CI
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
AQ
Sector Update: Health Care Stocks Ease Wednesday Afternoon
MT
CorMedix Remains Encouraged on DefenCath Opportunity, RBC Says
MT
RBC Trims Price Target on CorMedix to $9 From $10, Keeps Outperform Rating, Speculative Risk Qualifier
MT
Transcript : CorMedix Inc., Q4 2023 Earnings Call, Mar 12, 2024
CorMedix: Q4 Earnings Snapshot
AQ
CorMedix Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AQ
CorMedix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRMD Stock
  4. News CorMedix Inc.